vs

Side-by-side financial comparison of Crown Castle (CCI) and Edwards Lifesciences (EW). Click either name above to swap in a different company.

Edwards Lifesciences is the larger business by last-quarter revenue ($1.6B vs $1.0B, roughly 1.6× Crown Castle). Edwards Lifesciences runs the higher net margin — 23.1% vs -45.9%, a 69.0% gap on every dollar of revenue. On growth, Edwards Lifesciences posted the faster year-over-year revenue change (16.7% vs -4.8%). Over the past eight quarters, Edwards Lifesciences's revenue compounded faster (9.7% CAGR vs -4.5%).

Crown Castle Inc. is a real estate investment trust and provider of shared communications infrastructure in the United States headquartered in Houston, Texas. Operating with 100 offices worldwide, its network includes over 40,000 cell towers and approximately 85,000 route miles of fiber supporting small cells and fiber systems.

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

CCI vs EW — Head-to-Head

Bigger by revenue
EW
EW
1.6× larger
EW
$1.6B
$1.0B
CCI
Growing faster (revenue YoY)
EW
EW
+21.5% gap
EW
16.7%
-4.8%
CCI
Higher net margin
EW
EW
69.0% more per $
EW
23.1%
-45.9%
CCI
Faster 2-yr revenue CAGR
EW
EW
Annualised
EW
9.7%
-4.5%
CCI

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CCI
CCI
EW
EW
Revenue
$1.0B
$1.6B
Net Profit
$-464.0M
$380.7M
Gross Margin
78.0%
Operating Margin
46.0%
1.8%
Net Margin
-45.9%
23.1%
Revenue YoY
-4.8%
16.7%
Net Profit YoY
6.8%
EPS (diluted)
$1.48
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCI
CCI
EW
EW
Q1 26
$1.0B
$1.6B
Q4 25
$1.1B
$1.6B
Q3 25
$1.1B
$1.6B
Q2 25
$1.1B
$1.5B
Q1 25
$1.1B
$1.4B
Q4 24
$1.1B
$1.4B
Q3 24
$1.1B
$1.4B
Q2 24
$1.1B
$1.4B
Net Profit
CCI
CCI
EW
EW
Q1 26
$-464.0M
$380.7M
Q4 25
$294.0M
$91.2M
Q3 25
$323.0M
$291.1M
Q2 25
$291.0M
$333.2M
Q1 25
$-464.0M
$358.0M
Q4 24
$385.6M
Q3 24
$303.0M
$3.1B
Q2 24
$251.0M
$366.3M
Gross Margin
CCI
CCI
EW
EW
Q1 26
78.0%
Q4 25
97.4%
78.1%
Q3 25
97.2%
77.8%
Q2 25
97.5%
77.5%
Q1 25
97.4%
78.7%
Q4 24
97.7%
78.9%
Q3 24
97.6%
80.6%
Q2 24
97.7%
79.9%
Operating Margin
CCI
CCI
EW
EW
Q1 26
46.0%
1.8%
Q4 25
48.8%
9.6%
Q3 25
49.0%
19.8%
Q2 25
47.7%
26.8%
Q1 25
49.1%
27.9%
Q4 24
51.0%
22.6%
Q3 24
47.5%
25.9%
Q2 24
44.7%
26.8%
Net Margin
CCI
CCI
EW
EW
Q1 26
-45.9%
23.1%
Q4 25
27.5%
5.8%
Q3 25
30.1%
18.7%
Q2 25
27.5%
21.7%
Q1 25
-43.7%
25.3%
Q4 24
27.8%
Q3 24
27.1%
226.7%
Q2 24
22.7%
26.7%
EPS (diluted)
CCI
CCI
EW
EW
Q1 26
$1.48
$0.66
Q4 25
$0.67
$0.16
Q3 25
$0.74
$0.50
Q2 25
$0.67
$0.56
Q1 25
$-1.07
$0.61
Q4 24
$0.65
Q3 24
$0.70
$5.13
Q2 24
$0.58
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCI
CCI
EW
EW
Cash + ST InvestmentsLiquidity on hand
$55.0M
Total DebtLower is stronger
Stockholders' EquityBook value
Total Assets
$31.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCI
CCI
EW
EW
Q1 26
$55.0M
Q4 25
$99.0M
$4.2B
Q3 25
$57.0M
$3.8B
Q2 25
$94.0M
$4.1B
Q1 25
$60.0M
$3.9B
Q4 24
$100.0M
$4.0B
Q3 24
$194.0M
$4.4B
Q2 24
$155.0M
$2.0B
Total Debt
CCI
CCI
EW
EW
Q1 26
Q4 25
$21.6B
Q3 25
$21.6B
Q2 25
$22.0B
Q1 25
$22.9B
Q4 24
$23.5B
Q3 24
$23.5B
Q2 24
$22.9B
Stockholders' Equity
CCI
CCI
EW
EW
Q1 26
Q4 25
$-1.6B
$10.3B
Q3 25
$-1.5B
$10.2B
Q2 25
$-1.4B
$10.5B
Q1 25
$-1.3B
$10.1B
Q4 24
$-133.0M
$10.0B
Q3 24
$5.3B
$9.5B
Q2 24
$5.7B
$7.4B
Total Assets
CCI
CCI
EW
EW
Q1 26
$31.4B
Q4 25
$31.5B
$13.7B
Q3 25
$31.5B
$13.3B
Q2 25
$31.6B
$13.5B
Q1 25
$31.8B
$13.0B
Q4 24
$32.7B
$13.1B
Q3 24
$38.0B
$13.0B
Q2 24
$38.2B
$10.1B
Debt / Equity
CCI
CCI
EW
EW
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
4.43×
Q2 24
4.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCI
CCI
EW
EW
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$-43.0M
FCF MarginFCF / Revenue
-4.3%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$4.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCI
CCI
EW
EW
Q1 26
Q4 25
$3.1B
$450.9M
Q3 25
$714.0M
$573.7M
Q2 25
$832.0M
$290.2M
Q1 25
$641.0M
$280.4M
Q4 24
$2.9B
$-127.5M
Q3 24
$699.0M
$351.8M
Q2 24
$768.0M
$371.5M
Free Cash Flow
CCI
CCI
EW
EW
Q1 26
$-43.0M
Q4 25
$2.9B
$353.5M
Q3 25
$671.0M
$516.2M
Q2 25
$792.0M
$240.9M
Q1 25
$601.0M
$224.4M
Q4 24
$2.8B
$-177.3M
Q3 24
$661.0M
$299.9M
Q2 24
$729.0M
$286.1M
FCF Margin
CCI
CCI
EW
EW
Q1 26
-4.3%
Q4 25
268.4%
22.5%
Q3 25
62.6%
33.2%
Q2 25
74.7%
15.7%
Q1 25
56.6%
15.9%
Q4 24
247.3%
-12.8%
Q3 24
59.0%
22.1%
Q2 24
65.9%
20.9%
Capex Intensity
CCI
CCI
EW
EW
Q1 26
1.0%
Q4 25
17.0%
6.2%
Q3 25
4.0%
3.7%
Q2 25
3.8%
3.2%
Q1 25
3.8%
4.0%
Q4 24
15.7%
3.6%
Q3 24
3.4%
3.8%
Q2 24
3.5%
6.2%
Cash Conversion
CCI
CCI
EW
EW
Q1 26
Q4 25
10.40×
4.94×
Q3 25
2.21×
1.97×
Q2 25
2.86×
0.87×
Q1 25
0.78×
Q4 24
-0.33×
Q3 24
2.31×
0.11×
Q2 24
3.06×
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCI
CCI

Site rental$961.0M95%
Services and other$49.0M5%

EW
EW

Segment breakdown not available.

Related Comparisons